Cardiorenal dysfunction

AACN Advanced Critical Care

Volumn 21, Issue 4, 2010, Pages 357-364

  Merhaut, Shawn ^a,b   Trupp, Robin J ^a,c  

^a Society of Chest Pain Centers   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Sevamed Institute   (United States)

Author keywords

cardiorenal syndrome; CRS; decom pensated heart failure

Indexed keywords

DIURETIC AGENT; VASODILATOR AGENT; VASOPRESSIN RECEPTOR;

ACUTE DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLASSIFICATION; DRUG ANTAGONISM; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; PATHOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; SYNDROME; ULTRAFILTRATION;

ACUTE DISEASE; CHRONIC DISEASE; DIURETICS; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; RECEPTORS, VASOPRESSIN; RENAL DIALYSIS; SYNDROME; ULTRAFILTRATION; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78649432133     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/NCI.0b013e3181f7b4db     Document Type: Article

References (28)

1. Ronco C, McCullough P, Anker SD, et al. Cardiorenal syndrome: report from the consensus conference on the Acute Dialysis Quality Initiative. Eur Heart J. 2010;31:703-711.
2. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527-1539.
3. Rastogi A, Fonarow GC. The cardiorenal connection in heart failure. Curr Cardiol Rep. 2008;10:190-197.
4. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol. 2006;1:8-18.
5. Brewster UC, Setaro J F, Perazella MA. The reninangiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci. 2003;326:15-24.
6. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Arch Intern Med. 1988;148:2013-2016.
7. McCullough PA, Haapio M, Mankad S, et al. Prevention of cardiorenal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010;25:1777-1784.
8. Latchamsetty R, Fang J, Kline-Rogers E, et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am J Cardiol. 2007;99:939-942.
9. Heywood J T, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118, 645 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422-430.
10. Smit GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail. 2003;9:13-25.
11. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61-67. (Pubitemid 38045917)
12. Wencker D. Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure. Curr Heart Fail Rep. 2007;4:134-138.
13. Fonarow GC, Heywood J T. The confounding issue of comorbid renal insufficiency. Am J Med. 2006;119(suppl 1): S17-S25.
14. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663.
15. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154-2169.
16. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. J Am Coll Cardiol. 2005;46(6):1116-1143.
17. Felker GM on behalf of the NHLBI Heart Failure Clinical Research Network. Diuretic optimization strategies evaluation in acute heart failure. Paper presented at: 2010 American College of Cardiology & i2 Summit; March 2010; Atlanta, GA.
18. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9:1064-1069.
19. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol. 2008;52(8):599-604.
20. Fishbane S, Durham J, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol. 2004;15:251-260.
21. Mentzer RM, Oz M, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. J Am Coll Cardiol. 2007;49(6):716-726.
22. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239-1312.
23. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol. 2003;42(2):201-208.
24. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol. 2005;46(11):2047-2051.
25. Costanzo MR, Guglin ME, Saltzberg M T, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49(6):675-683.
26. 2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355(20):2099-2112.
27. Gheorghiade M, Konstam MA, Burnett JC. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVER-EST clinical status trials. JAMA. 2007;297(12):1332-1343.
28. 2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction. J Am Coll Cardiol. 2008;52(19):1540-1545.